Cargando…

Increased delta variant SARS-CoV-2 infections in a highly vaccinated medical center in Japan

The Delta variant has dominated SARS-CoV-2 infections in Tokyo, Japan from June 2021 to date. We conducted a retrospective cohort study to assess BNT162b2 vaccine effectiveness during the surge in Delta among 3,911 healthcare workers (HCWs) at a medical center of Tokyo with a high vaccination rate o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Yan, Naito, Toshio, Tabe, Yoko, Ito, Kanami, Nojiri, Shuko, Deshpande, Gautam A., Seyama, Kuniaki, Takahashi, Kazuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Author(s). Published by Elsevier Ltd. 2022
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9001195/ https://www.ncbi.nlm.nih.gov/pubmed/35465978 http://dx.doi.org/10.1016/j.vaccine.2022.04.029

Ejemplares similares

Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan
por: Naito, Toshio, et al.
Publicado: (2021)

Antibody response and seroprevalence in healthcare workers after the BNT162b2 vaccination in a University Hospital at Tokyo
por: Igawa, Gene, et al.
Publicado: (2022)

Increased SARS-CoV-2 seroprevalence and spread of infection without awareness among healthcare workers through 2020–2022 in a Japanese medical center
por: Kanamori, Rie, et al.
Publicado: (2023)

SARS-CoV-2 evolution among patients with immunosuppression in a nosocomial cluster of a Japanese medical center during the Delta (AY.29 sublineage) surge
por: Hosaka, Yoshie, et al.
Publicado: (2023)

Reactogenicity following two doses of the BNT162b2 mRNA COVID-19 vaccine: Real-world evidence from healthcare workers in Japan
por: Saita, Mizue, et al.
Publicado: (2022)

Elevated depressive symptoms among newer and younger healthcare workers in Japan during the COVID‐19 pandemic
por: Katsuta, Narimasa, et al.
Publicado: (2021)

Molecular characterization of SARS-CoV-2 detected in Tokyo, Japan during five waves: Identification of the amino acid substitutions associated with transmissibility and severity
por: Tsuchiya, Koji, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Fukuda, Hiroshi, et al.
Publicado: (2021)

Author Correction: SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo
por: Fukuda, Hiroshi, et al.
Publicado: (2021)

Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment
por: Takahashi, Maika, et al.
Publicado: (2023)

Mortality Prediction of COVID-19 in Hospitalized Patients Using the 2020 Diagnosis Procedure Combination Administrative Database of Japan
por: Nojiri, Shuko, et al.
Publicado: (2022)

Preoperative Universal SARS-CoV-2 Screening for Asymptomatic Patients: A Report From Tokyo, Japan
por: Komori, Akira, et al.
Publicado: (2021)

Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan
por: Jin, Bo, et al.
Publicado: (2023)

Circulating tumor necrosis factor receptors are associated with mortality and disease severity in COVID-19 patients
por: Gohda, Tomohito, et al.
Publicado: (2022)

Atherosclerotic Cardiovascular Risk in Japan
por: Nojiri, Shuko, et al.
Publicado: (2017)

Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccination
por: Takahashi, Toshihiro, et al.
Publicado: (2023)

Relative instantaneous reproduction number of Omicron SARS‐CoV‐2 variant with respect to the Delta variant in Denmark
por: Ito, Kimihito, et al.
Publicado: (2022)

Comorbidity status in hospitalized elderly in Japan: Analysis from National Database of Health Insurance Claims and Specific Health Checkups
por: Nojiri, Shuko, et al.
Publicado: (2019)

Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies
por: Takahashi, Maika, et al.
Publicado: (2022)

Increased suicidal ideation in the COVID-19 pandemic: an employee cohort in Japan
por: Sasaki, Natsu, et al.
Publicado: (2021)

RS3PE Syndrome with Subsequent PMR Caused by Long-Term DPP-4 Inhibitor Use
por: Takahashi, Yuichi, et al.
Publicado: (2023)

Benign clear cell “sugar” tumor of the lung in a patient with Birt-Hogg-Dubé syndrome: a case report
por: Gunji-Niitsu, Yoko, et al.
Publicado: (2016)

Clinical and genetic spectrum of Birt–Hogg–Dubé syndrome patients in whom pneumothorax and/or multiple lung cysts are the presenting feature
por: Kunogi, Makiko, et al.
Publicado: (2010)

COVID‐19 severity from Omicron and Delta SARS‐CoV‐2 variants
por: Wrenn, Jesse O., et al.
Publicado: (2022)

The deterioration of mental health among healthcare workers during the COVID-19 outbreak: A population-based cohort study of workers in Japan
por: Sasaki, Natsu, et al.
Publicado: (2020)

Effectiveness of messenger RNA vaccines against infection with SARS-CoV-2 during the periods of Delta and Omicron variant predominance in Japan: the Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
por: Mimura, Wataru, et al.
Publicado: (2022)

Breakthrough infections with the SARS-CoV-2 Delta variant: vaccinations halved transmission risk
por: Hsu, L., et al.
Publicado: (2022)

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021
por: Ito, Kimihito, et al.
Publicado: (2021)

COVID-19 Delta variants—Current status and implications as of August 2021
por: Yu, Flora, et al.
Publicado: (2021)

Differences in the case fatality risks associated with SARS-CoV-2 Delta and non-Delta variants in relation to vaccine coverage: An early ecological study in the United Kingdom
por: Zhao, Shi, et al.
Publicado: (2022)

Codon usage divergence in Delta variants (B.1.617.2) of SARS-CoV-2
por: Li, Gun, et al.
Publicado: (2022)

Shorter Incubation Period among Unvaccinated Delta Variant Coronavirus Disease 2019 Patients in Japan
por: Ogata, Tsuyoshi, et al.
Publicado: (2022)

National burden of the pharmaceutical cost of wet compresses and its cost predictors: nationwide cross-sectional study in Japan
por: Itoh, Hiroaki, et al.
Publicado: (2019)

Seroprevalence of anti-SARS-CoV-2 antibodies in Japanese COVID-19 patients
por: Hiki, Makoto, et al.
Publicado: (2021)

COVID-19 pandemic and the international classification of functioning in multiple system atrophy: a cross-sectional, nationwide survey in Japan
por: Haruyama, Koshiro, et al.
Publicado: (2022)

Estimating the incubation period of SARS-CoV-2 Omicron BA.1 variant in comparison with that during the Delta variant dominance in South Korea
por: Liu, Yanwen, et al.
Publicado: (2022)

From Delta to Omicron SARS-CoV-2 variant: Switch to saliva sampling for higher detection rate
por: Cornette, Margot, et al.
Publicado: (2022)

Longitudinal Analyses after COVID-19 Recovery or Prolonged Infection Reveal Unique Immunological Signatures after Repeated Vaccinations
por: Hisamatsu, Daisuke, et al.
Publicado: (2022)

Case fatality rate considering the lag time from the onset of COVID-19 infection to related death from 2020 to 2022 in Japan
por: Nojiri, Shuko, et al.
Publicado: (2023)

Difference of the progression of pulmonary cysts assessed by computed tomography among COPD, lymphangioleiomyomatosis, and Birt-Hogg-Dubé syndrome
por: Tobino, Kazunori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2k1eae22rondvhm09n6ho77bhb